<?xml version="1.0"?>
<Articles JournalTitle="Acta Medica Iranica">
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Acta Medica Iranica</JournalTitle>
      <Issn>0044-6025</Issn>
      <Volume>51</Volume>
      <Issue>12</Issue>
      <PubDate PubStatus="epublish">
        <Year>2013</Year>
        <Month>12</Month>
        <Day>15</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">MicroRNAs Horizon in Retinoblastoma</title>
    <FirstPage>823</FirstPage>
    <LastPage>829</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Mojgan</FirstName>
        <LastName>Mirakholi</LastName>
        <affiliation locale="en_US">Department of Pathology, Faculty of Medicine and Health Sciences, University Putra Malaysia, 43400 UPM Serdang, Malaysia.</affiliation>
      </Author>
      <Author>
        <FirstName>Touraj</FirstName>
        <LastName>Mahmoudi</LastName>
        <affiliation locale="en_US">Department of Cancer, Research Center for Gastroenterology and Liver Diseases (RCGLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Mansour</FirstName>
        <LastName>Heidari</LastName>
        <affiliation locale="en_US">Department of Medical Genetics, Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran. AND Stem Cell Preparation Unit, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2015</Year>
        <Month>10</Month>
        <Day>11</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">In the retinoblastoma research, it is of great interest to identify molecular markers associated with the genetics of tumorigenesis. microRNAs (miRNAs) are small non-coding RNA molecules that play a regulatory role in many crucial cellular pathways such as differentiation, cell cycle progression, and apoptosis. A body of evidences showed dysregulation of miRNAs in tumor biology and many diseases. They potentially play a significant role in tumorigenesis processes and have been the subject of research in many types of cancers including retinal tumorigenesis. miRNA expression profiling was found to be associated with tumor development, progression and treatment. These associations demonstrate the putative applications of miRNAs in monitoring of different aspect of tumors consisting diagnostic, prognostic and therapeutic. Herein, we review the current literature concerning to the study of miRNA target recognition, function to tumorigenesis and treatment in retinoblastoma. Identification the specific miRNA biomarkers associated with retinoblastoma cancer may help to establish new therapeutic approaches for salvage affected eyes in patients.</abstract>
    <web_url>https://acta.tums.ac.ir/index.php/acta/article/view/4338</web_url>
    <pdf_url>https://acta.tums.ac.ir/index.php/acta/article/download/4338/4527</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Acta Medica Iranica</JournalTitle>
      <Issn>0044-6025</Issn>
      <Volume>51</Volume>
      <Issue>12</Issue>
      <PubDate PubStatus="epublish">
        <Year>2013</Year>
        <Month>12</Month>
        <Day>15</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Chronic Effect of Gabapentin on Liver function in Adult Male Rats</title>
    <FirstPage>830</FirstPage>
    <LastPage>833</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Mohammad Hassan</FirstName>
        <LastName>Meshkibaf</LastName>
        <affiliation locale="en_US">Departments of Biochemistry, Fasa University of Medical Sciences, Fasa, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Behnoosh</FirstName>
        <LastName>Miladpoor</LastName>
        <affiliation locale="en_US">Departments of Biochemistry, Fasa University of Medical Sciences, Fasa, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Fateme</FirstName>
        <LastName>Shole Var</LastName>
        <affiliation locale="en_US">Departments of Biochemistry, Fasa University of Medical Sciences, Fasa, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Abbas</FirstName>
        <LastName>Abdollahi</LastName>
        <affiliation locale="en_US">Departments of Biochemistry, Fasa University of Medical Sciences, Fasa, Iran.</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2015</Year>
        <Month>10</Month>
        <Day>11</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Gabapentin (GPN) is a new antiepileptic agent currently in used as add-on therapy in adult patients suffering from partial seizures. The extent of liver damage at different dosage and long term treatment with GPN is not yet clear. Therefore this study was undertaken to find out the possibility of liver damage by this drug. Adult male (Wistar) rats of 180-220 g were administered intraperitoneally with GPN (20 or 100 mg/kg) for 45 days. After the experimental period, the liver function tests were carried out in control and experimental groups. The activity of liver enzymes, with 20 mg/kg of GPN were not significantly different from the control group but, the serum levels of aspartate aminotransferase, alanine aminotransferase, alkaline phosphatase, lactate dehydrogenase, direct bilirubin and total bilirubin were enhanced significantly with 100 mg/kg of GPN. Total protein and albumin decreased in this group as compared with control animals. The histopathology of the liver parenchymal cells also showed minute foci of necrosis in a few rats treated with high dose of GPN, whereas, at therapeutic dose the histopathology and biochemical indices showed almost normal values. At therapeutic dose GPN is a safer drug with regards to liver function and hepatocellular damage as compared with other antiepileptic drugs.</abstract>
    <web_url>https://acta.tums.ac.ir/index.php/acta/article/view/4337</web_url>
    <pdf_url>https://acta.tums.ac.ir/index.php/acta/article/download/4337/4530</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Acta Medica Iranica</JournalTitle>
      <Issn>0044-6025</Issn>
      <Volume>51</Volume>
      <Issue>12</Issue>
      <PubDate PubStatus="epublish">
        <Year>2013</Year>
        <Month>12</Month>
        <Day>15</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Differential Expression of Human Homeodomain TGIFLX in Brain Tumor Cell Lines</title>
    <FirstPage>834</FirstPage>
    <LastPage>841</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Reza</FirstName>
        <LastName>Raoofian</LastName>
        <affiliation locale="en_US">Department of Medical Genetics, Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Mohammad Reza</FirstName>
        <LastName>Noori-Daloii</LastName>
        <affiliation locale="en_US">Department of Medical Genetics, Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Samira</FirstName>
        <LastName>Saee-Rad</LastName>
        <affiliation locale="en_US">Department of Medical Genetics, Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Mohammad Hossein</FirstName>
        <LastName>Modarresi</LastName>
        <affiliation locale="en_US">Department of Medical Genetics, Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Seyed Hamid</FirstName>
        <LastName>Ghaffari</LastName>
        <affiliation locale="en_US">Hematology, Oncology and BMT Research Center, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Majid</FirstName>
        <LastName>Mojarrad</LastName>
        <affiliation locale="en_US">Department of Medical Genetics, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Farid</FirstName>
        <LastName>Abolhasani</LastName>
        <affiliation locale="en_US">Department of Anatomy, Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Mansour</FirstName>
        <LastName>Heidari</LastName>
        <affiliation locale="en_US">Department of Medical Genetics, Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran. AND Stem Cell Preparation Unit, Eye Research Center, Farabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2015</Year>
        <Month>10</Month>
        <Day>11</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Glioblastoma is the most common and the most lethal primary brain cancer. This malignancy is highly locally invasive, rarely metastatic and resistant to current therapies. Little is known about the distinct molecular biology of glioblastoma multiforme (GBM) in terms of initiation and progression. So far, several molecular mechanisms have been suggested to implicate in GBM development. Homeodomain (HD) transcription factors play central roles in the expression of genomic information in all known eukaryotes. The TGIFX homeobox gene was originally discovered in human adult testes. Our previous study showed implications of TGIFLX in prostate cancer and azoospermia, although the molecular mechanism by which TGIFLX acts is unknown. Moreover, studies reported that HD proteins are involved in normal and abnormal brain developments. We examined the expression pattern of TGIFLX in different human brain tumor cell lines including U87MG, A172, Daoy and 1321N1. Interestingly, real time RT-PCR and western blot analysis revealed a high level of TGIFLX expression in A172 cells but not in the other cell lines. We subsequently cloned the entire coding sequence of TGIFLX gene into the pEGFP-N1 vector, eukaryotic expression vector encoding eGFP, and transfected into the U-87 MG cell line. The TGIFLX-GFP expression was confirmed by real time RT-PCR and UV-microscopic analysis. Upon transfection into U87 cells, fusion protein TGIFLX-GFP was found to locate mainly in the nucleus. This is the first report to determine the nuclear localization of TGIFLX and evaluation of its expression level between different brain tumor cell lines. Our data also suggest that TGIFLX gene dysregulation could be involved in the pathogenesis of some human brain tumors.</abstract>
    <web_url>https://acta.tums.ac.ir/index.php/acta/article/view/4336</web_url>
    <pdf_url>https://acta.tums.ac.ir/index.php/acta/article/download/4336/4532</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Acta Medica Iranica</JournalTitle>
      <Issn>0044-6025</Issn>
      <Volume>51</Volume>
      <Issue>12</Issue>
      <PubDate PubStatus="epublish">
        <Year>2013</Year>
        <Month>12</Month>
        <Day>15</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Safety of Intramedullary Autologous Peripheral Nerve Grafts for Post-Rehabilitated Complete Motor Spinal Cord Injuries: A Phase I Study</title>
    <FirstPage>842</FirstPage>
    <LastPage>854</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Nazi</FirstName>
        <LastName>Derakhshanrad</LastName>
        <affiliation locale="en_US">Brain and Spinal Injuries Research Center, Imam Khomeini Hospital, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Hooshang</FirstName>
        <LastName>Saberi</LastName>
        <affiliation locale="en_US">Brain and Spinal Injuries Research Center, Imam Khomeini Hospital,&#xD;
Tehran University of Medical Sciences, Tehran, Iran. AND Department of Neurosurgery, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Sajad</FirstName>
        <LastName>Shafiee</LastName>
        <affiliation locale="en_US">Department of Neurosurgery, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Mir Saeed</FirstName>
        <LastName>Yekaninejad</LastName>
        <affiliation locale="en_US">Brain and Spinal Injuries Research Center, Imam Khomeini Hospital,&#xD;
Tehran University of Medical Sciences, Tehran, Iran. AND Department of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Mohammad Reza</FirstName>
        <LastName>Hadian</LastName>
        <affiliation locale="en_US">Brain and Spinal Injuries Research Center, Imam Khomeini Hospital,&#xD;
Tehran University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Abdolreza</FirstName>
        <LastName>Sheikhrezai</LastName>
        <affiliation locale="en_US">Brain and Spinal Injuries Research Center, Imam Khomeini Hospital,&#xD;
Tehran University of Medical Sciences, Tehran, Iran. AND Department of Neurosurgery, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Zahid</FirstName>
        <LastName>Hussain Khan</LastName>
        <affiliation locale="en_US">Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Abbas</FirstName>
        <LastName>Noruzi Javidan</LastName>
        <affiliation locale="en_US">Department of Neurosurgery, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Amir Hassan</FirstName>
        <LastName>Kohan</LastName>
        <affiliation locale="en_US">Brain and Spinal Injuries Research Center, Imam Khomeini Hospital,&#xD;
Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2015</Year>
        <Month>10</Month>
        <Day>11</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Many experimental studies have reported behavioral improvement after transplantation of peripheral nerve tissue into the contused spinal cord, even in large animals. The safety of this treatment in human remains unknown. In this translational phase 1 study, safety of peripheral nerve grafting for chronic spinal cord injuries and possible outcomes are being reported. Twelve complete motor spinal cord injury patients, who had finished their rehabilitation program, were enrolled. There were 4 thoracic and 8 cervical cases. Patients underwent sural nerve preconditioning in the calf, followed 1 week later, by intramedullary transplantation of the harvested nerve fascicles. The patients were followed up for potential complications periodically, and final assessment by American Spinal Injury association (ASIA) and Spinal Cord Independence Measure (SCIM) III were reported after 2 years of follow-up. The median duration of the spinal cord injury was 31 months. At two years of follow up, out of 7 cases with ASIA Impairment Scale (AIS) A, 4(57.1%) cases improved to AIS B and 1 (14.3%) case became AIS C. There were 1 patient with transient increased spasm, one case of transient cystitis, 3 patients with transient increased neuropathic pain and 1 case with transient episode of autonomic dysreflexia, all being managed medically. There was no case of donor site infection. The above complications were transient as they responded to temporary medical treatment. It may be deduced that after two years follow-up of patients that the procedure may be safe, however further controlled studies are needed to prove its efficacy.</abstract>
    <web_url>https://acta.tums.ac.ir/index.php/acta/article/view/4335</web_url>
    <pdf_url>https://acta.tums.ac.ir/index.php/acta/article/download/4335/4535</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Acta Medica Iranica</JournalTitle>
      <Issn>0044-6025</Issn>
      <Volume>51</Volume>
      <Issue>12</Issue>
      <PubDate PubStatus="epublish">
        <Year>2013</Year>
        <Month>12</Month>
        <Day>15</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">The Impact of Alendronate on Bone Mineral Density of Osteoporotic Patients</title>
    <FirstPage>855</FirstPage>
    <LastPage>860</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Hamidreza</FirstName>
        <LastName>Aghaei-Meybodi</LastName>
        <affiliation locale="en_US">Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Negin</FirstName>
        <LastName>Rashidi</LastName>
        <affiliation locale="en_US">Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Mahdi</FirstName>
        <LastName>Montazeri</LastName>
        <affiliation locale="en_US">Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Abbasali</FirstName>
        <LastName>Keshtkar</LastName>
        <affiliation locale="en_US">Osteoporosis Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Patricia</FirstName>
        <LastName>Khashayar</LastName>
        <affiliation locale="en_US">Osteoporosis Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2015</Year>
        <Month>10</Month>
        <Day>11</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">The present study assessed the real life therapeutic effects of weekly doses of alendronate in treating a group of osteoporotic patients in Iran. The present historical cohort was conducted on patients who had undergone two or more bone mineral densitometry within an interval of 1.5-2 years in Shariati Hospital bone mineral density department between 2002 and 2010.patients were asked by phone about consumption of alendronate. The mean increase in the BMD values at different sites was calculated. There was a significant increase in the body mass index (BMI) values of both the individuals taking alendronate and the control group (P&lt;0.001). Taking the weekly dosage of the drug was associated with a 7.67% increase in the BMD values at the femoral neck, 8.68% at the total hip, and 3.17% at the lumbar spine. Moreover, our results showed a significant difference between the height decline in the two groups (alendronate taking: 0.7&#xB1;2.4 vs. control: -0.7&#xB1;2.6, P&lt;0.001). Comparing the results of the present study with that of previous ones revealed the drug is beneficial in improving bone mineral density in Iranians; as well alendronate is more effective in Iranian postmenopausal women when compared with the Americans.</abstract>
    <web_url>https://acta.tums.ac.ir/index.php/acta/article/view/4334</web_url>
    <pdf_url>https://acta.tums.ac.ir/index.php/acta/article/download/4334/4537</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Acta Medica Iranica</JournalTitle>
      <Issn>0044-6025</Issn>
      <Volume>51</Volume>
      <Issue>12</Issue>
      <PubDate PubStatus="epublish">
        <Year>2013</Year>
        <Month>12</Month>
        <Day>15</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Can Preoperative Serum Level of Creatinine Predict New-Onset Atrial Fibrillation in Non-Diabetic Male Patients Undergoing Open Heart Surgery? A Retrograde View</title>
    <FirstPage>861</FirstPage>
    <LastPage>863</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Seyed Jalil</FirstName>
        <LastName>Mirhosseini</LastName>
        <affiliation locale="en_US">Department of Cardiovascular Surgery, Afshar Hospital, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Sadegh</FirstName>
        <LastName>Ali-Hassan-Sayegh</LastName>
        <affiliation locale="en_US">Yazd Cardiovascular Researches Center, Afshar Hospital, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Ali Akbar</FirstName>
        <LastName>Karimi-Bondarabadi</LastName>
        <affiliation locale="en_US">Yazd Cardiovascular Researches Center, Afshar Hospital, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Mohammad Reza</FirstName>
        <LastName>Mozayan</LastName>
        <affiliation locale="en_US">Yazd Cardiovascular Researches Center, Afshar Hospital, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2015</Year>
        <Month>10</Month>
        <Day>11</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Renal dysfunction is a risk marker in patients who candidate for coronary artery bypass graft (CABG). Renal disorder is associated with prolonged stays in intensive care unit and hospital, morbidity and mortality. Aim of this study is specific evaluation of association between preoperative creatinine (Cr) with atrial fibrillation (AF) after elective off-pump CABG in non-diabetic male patients with normal ejection fraction. Two hundred non-diabetic male patients with normal ejection fraction undergoing elective off pump CABG surgery enrolled in this cross-sectional study and were stratified by present or absence of postoperative atrial fibrillation: patients with postoperative new-onset atrial fibrillation (n=100) as group 1 and patients without new-onset postoperative atrial fibrillation as group 2 (n=100). Preoperative serological test of the participants, such as serum creatinine, were recorded in their medical dossiers. Data were analyzed in SPSS-16 software and tested for association between atrial fibrillation with creatinine level by using student t test, chi-square test or logistic regression. Cr level in patients with and without AF three days before surgery were 1.8&#xB1;0.3 and 1.0&#xB1;0.4 respectively (P value for Cr=0.00). On surgical day, mean Cr level in patients with and without AF were 1.6&#xB1;0.2 and 1.1&#xB1;0.5 respectively (P value for Cr = 0.00). Of the 100, male patients with postoperative AF, duration and frequency of recurrence of AF were not associated with Cr at three days before surgery and on surgical days (P&gt;0.05). Patients with postoperative AF had unsuitable status of renal function compare to patients without AF; however, preoperative serum creatinine cannot associate with duration and frequency of recurrence of AF.</abstract>
    <web_url>https://acta.tums.ac.ir/index.php/acta/article/view/4333</web_url>
    <pdf_url>https://acta.tums.ac.ir/index.php/acta/article/download/4333/4538</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Acta Medica Iranica</JournalTitle>
      <Issn>0044-6025</Issn>
      <Volume>51</Volume>
      <Issue>12</Issue>
      <PubDate PubStatus="epublish">
        <Year>2013</Year>
        <Month>12</Month>
        <Day>15</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Chlamydia Pneumoniae in the Atherosclerotic Plaques of Coronary Artery Disease Patients</title>
    <FirstPage>864</FirstPage>
    <LastPage>870</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Morteza</FirstName>
        <LastName>Izadi</LastName>
        <affiliation locale="en_US">Health Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Mozhgan</FirstName>
        <LastName>Fazel</LastName>
        <affiliation locale="en_US">International Travel Medicine Center of Iran, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Mohsen</FirstName>
        <LastName>Akrami</LastName>
        <affiliation locale="en_US">International Travel Medicine Center of Iran, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Seyed Hassan</FirstName>
        <LastName>Saadat</LastName>
        <affiliation locale="en_US">International Travel Medicine Center of Iran, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Bahram</FirstName>
        <LastName>Pishgoo</LastName>
        <affiliation locale="en_US">International Travel Medicine Center of Iran, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Mohammad Hassan</FirstName>
        <LastName>Nasseri</LastName>
        <affiliation locale="en_US">International Travel Medicine Center of Iran, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Hossein</FirstName>
        <LastName>Dabiri</LastName>
        <affiliation locale="en_US">Department of Medical Microbiology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Reza</FirstName>
        <LastName>SafiAryan</LastName>
        <affiliation locale="en_US">Health Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Ali Akbar</FirstName>
        <LastName>Esfahani</LastName>
        <affiliation locale="en_US">Health Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Ali</FirstName>
        <LastName>Ahmadi</LastName>
        <affiliation locale="en_US">Health Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Davood</FirstName>
        <LastName>Kazemi-Saleh</LastName>
        <affiliation locale="en_US">Health Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Mohammad Hassan</FirstName>
        <LastName>Kalantar-Motamed</LastName>
        <affiliation locale="en_US">Health Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Saeed</FirstName>
        <LastName>Taheri</LastName>
        <affiliation locale="en_US">Dr Taheri Medical Research Group, Tehran, Iran.</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2015</Year>
        <Month>10</Month>
        <Day>11</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">An association between Chlamydia pneumoniae (C. pneumoniae) and cardiovascular disease has been demonstrated. In this study, we aimed to study this potential relationship in 105 Iranian patients. Coronary artery specimens from 105 Iranian patients undergoing CABG were analyzed by PCR method for C. pneumoniae. Serological evaluation for C. pneumoniae IgG and IgM was performed using ELISA. 53 specimens from mamillary artery were also investigated. C. pneumoniae PCR test result was positive for 23 (21.9%) of patients with coronary artery atherosclerosis, but none of the specimens from the mamillary artery was positive for C. pneumoniae when it was evaluated by the PCR (P&lt;0.001). Coronary artery disease patients with and without a history of unstable angina or myocardial infarction were comparable in C. pneumoniae PCR test positive rates (P=0.618). Relevance of IgG and IgM positivity were also studied by correlating it to the study parameters, but no difference was found. CRP was significantly higher in the IgM positive group (P&lt;0.001). A significant proportion of coronary atherosclerotic plaques are infected with C. pneumoniae while no infection was found in the normal mamillary artery specimens. No association was found between acute coronary syndromes and serological and PCR positivity. Further prospective randomized controlled studies with large patient population are needed to confirm our findings.</abstract>
    <web_url>https://acta.tums.ac.ir/index.php/acta/article/view/4332</web_url>
    <pdf_url>https://acta.tums.ac.ir/index.php/acta/article/download/4332/4541</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Acta Medica Iranica</JournalTitle>
      <Issn>0044-6025</Issn>
      <Volume>51</Volume>
      <Issue>12</Issue>
      <PubDate PubStatus="epublish">
        <Year>2013</Year>
        <Month>12</Month>
        <Day>15</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Antibiotics Induced Acute Kidney Injury: Incidence, Risk Factors, Onset Time and Outcome</title>
    <FirstPage>871</FirstPage>
    <LastPage>878</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Hossein</FirstName>
        <LastName>Khalili</LastName>
        <affiliation locale="en_US">Department of Clinical Pharmacy, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Samaneh</FirstName>
        <LastName>Bairami</LastName>
        <affiliation locale="en_US">Research Center for Rational Use of Drugs, Department of Clinical Pharmacy, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Mona</FirstName>
        <LastName>Kargar</LastName>
        <affiliation locale="en_US">Research Center for Rational Use of Drugs, Department of Clinical Pharmacy, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2015</Year>
        <Month>10</Month>
        <Day>11</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Drug induced acute kidney injury (AKI) has been implicated in 8% to 60% of all cases of in-hospital AKI and as such is a recognized source of significant morbidity and mortality. Evaluation of incidence, risk factors, onset time, and outcome of&#xA0; antibiotics' associated acute kidney injury. During one-year period, all patients who developed acute kidney injury during their hospital stay in the infectious diseases ward of Imam Khomeini hospital were included in the study prospectively. Patients' demographic data, baseline diseases, cause of current hospital admission, history of past and current medications and hemodynamic parameters were collected and monitored closely. Drug induced acute kidney injury was defined based on acute kidney injury network criteria. From 424 admitted patients, 76 (17.9%) developed acute kidney injury. Aminoglycosides (gentamicin and amikacin), amphotericin B, vancomycin, beta-lactam antibiotics (cefazolin and ceftriaxone) in monotherapy and combination therapy were the causes of acute kidney injury in most of the patients. From the co-morbid diseases in patients with acute kidney injury, diabetes mellitus (26.3%) and hypertension (5.5%), were the most frequent ones. Presence of diabetes mellitus as comorbidity (OR=2.6; CI=1.3-5.7, P=0.01), dehydration of patients upon admission (OR=3.4; CI=1.9-6.4, P&lt;0.001), and administration of nephrotoxic combinations (OR=2.1; CI=1.2-4.1, P=0.04) were independent risk factors for antibiotic induced nephrotoxicity in our study. About 18% of the patients developed acute kidney injury during their hospitalization period in the infectious diseases ward. Aminoglycosides, amphotericin B, vancomycin and beta-lactam antibiotics were responsible agents for acute kidney injury in this study.</abstract>
    <web_url>https://acta.tums.ac.ir/index.php/acta/article/view/4331</web_url>
    <pdf_url>https://acta.tums.ac.ir/index.php/acta/article/download/4331/4544</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Acta Medica Iranica</JournalTitle>
      <Issn>0044-6025</Issn>
      <Volume>51</Volume>
      <Issue>12</Issue>
      <PubDate PubStatus="epublish">
        <Year>2013</Year>
        <Month>12</Month>
        <Day>15</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Clinicopathological Study of 1016 Consecutive Adnexal Skin Tumors</title>
    <FirstPage>879</FirstPage>
    <LastPage>885</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Kambiz</FirstName>
        <LastName>Kamyab-Hesari</LastName>
        <affiliation locale="en_US">Department of Dermatopathology, Razi Hospital, Tehran University of Medical Sciences. Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Kamran</FirstName>
        <LastName>Balighi</LastName>
        <affiliation locale="en_US">Department of dermatology, Razi Hospital , Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Nasim</FirstName>
        <LastName>Afshar</LastName>
        <affiliation locale="en_US">Department of dermatology, Razi Hospital , Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Nessa</FirstName>
        <LastName>Aghazadeh</LastName>
        <affiliation locale="en_US">Department of dermatology, Razi Hospital , Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Ziba</FirstName>
        <LastName>Rahbar</LastName>
        <affiliation locale="en_US">Department of dermatology, Razi Hospital , Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Maryam</FirstName>
        <LastName>Seraj</LastName>
        <affiliation locale="en_US">Department of dermatology, Razi Hospital , Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Maede</FirstName>
        <LastName>Rayati</LastName>
        <affiliation locale="en_US">Department of dermatology, Razi Hospital , Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2015</Year>
        <Month>10</Month>
        <Day>11</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Adnexal tumors (ATs) are primary skin tumors with benign or rarely, malignant behavior. They have been classified based on differentiation towards hair follicle, sebaceous, apocrine or eccrine gland. Few large-scale studies have focused on ATs. To determine the prevalence of ATs and to assess clinical and histopathological trend of ATs. A retrospective descriptive study of all ATs diagnosed in Razi hospital between 2006 and 2010 was performed. A total of 30,000 pathology records were reviewed, and 1016 ATs were included. The prevalence of ATs was 3.3%. 518 patients (51%) were female, with a mean age of 34.5 years. 953 tumors (93.8%) were benign. ATs were most commonly located in the head and neck area (822, 83.5%). The most common histopathological origin of ATs was sebaceous gland (536, 52.7%). Sebaceous nevus of Jadassohn was the most prevalent single tumor type (40.6% of all ATs). In 63.6% (646) of tumors, ATs were clinically suspected by the clinician prior to biopsy. The most common malignant AT was sebaceous carcinoma (23, 36.5% of all malignant ATs). ATs are infrequent lesions, most commonly occurring in 3rd and 4th decade of life. Diagnosis of ATs is made by histopathological studies as they often express indistinctive clinical features. Malignant ATs are rare, occur at an older age, and are often hard to recognize clinically.</abstract>
    <web_url>https://acta.tums.ac.ir/index.php/acta/article/view/4330</web_url>
    <pdf_url>https://acta.tums.ac.ir/index.php/acta/article/download/4330/4546</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Acta Medica Iranica</JournalTitle>
      <Issn>0044-6025</Issn>
      <Volume>51</Volume>
      <Issue>12</Issue>
      <PubDate PubStatus="epublish">
        <Year>2013</Year>
        <Month>12</Month>
        <Day>15</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Tinnitus: An Epidemiologic Study in Iranian Population</title>
    <FirstPage>886</FirstPage>
    <LastPage>891</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Maryam</FirstName>
        <LastName>Jalessi</LastName>
        <affiliation locale="en_US">Department of ENT-Head and Neck Surgery, ENT-Head and Neck Surgery Research Center, Rasool Akram Hospital, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Mohammad</FirstName>
        <LastName>Farhadi</LastName>
        <affiliation locale="en_US">Department of ENT-Head and Neck Surgery, ENT-Head and Neck Surgery Research Center, Rasool Akram Hospital, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Alimohamad</FirstName>
        <LastName>Asghari</LastName>
        <affiliation locale="en_US">Department of ENT-Head and Neck Surgery, ENT-Head and Neck Surgery Research Center, Rasool Akram Hospital, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Seyed Kamran</FirstName>
        <LastName>Kamrava</LastName>
        <affiliation locale="en_US">Department of ENT-Head and Neck Surgery, ENT-Head and Neck Surgery Research Center, Rasool Akram Hospital, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Ebrahim</FirstName>
        <LastName>Amintehran</LastName>
        <affiliation locale="en_US">Department of ENT-Head and Neck Surgery, ENT-Head and Neck Surgery Research Center, Rasool Akram Hospital, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Suzan</FirstName>
        <LastName>Ghalehbaghi</LastName>
        <affiliation locale="en_US">Department of Family Planning and Population Control, Islamic Azad University South Tehran Branch, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Ashkan</FirstName>
        <LastName>Heshmatzadeh Behzadi</LastName>
        <affiliation locale="en_US">Department of ENT-Head and Neck Surgery, ENT-Head and Neck Surgery Research Center, Rasool Akram Hospital, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Seyed Behzad</FirstName>
        <LastName>Pousti</LastName>
        <affiliation locale="en_US">Department of ENT-Head and Neck Surgery, ENT-Head and Neck Surgery Research Center, Rasool Akram Hospital, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2015</Year>
        <Month>10</Month>
        <Day>11</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">A wide range of population, 4% to 30%, suffers from tinnitus that is defined as perception of sound without apparent acoustic stimulus. We conducted the present study to determine the prevalence of tinnitus in Iranian population; Tehran province. This cross-sectional study was conducted from January 2009 to December 2009, recruiting 3207 individuals (age range, 7-98) who were residing in Tehran province, Iran. Participants were asked to fill two questionnaires; the validated Persian version of Tinnitus Questionnaire (TQ) and another one that was specifically designed for this study. Prevalence of tinnitus and its association factors were evaluated. 3207 participants enrolled into our study comprising 1429 (44.7%) male and 1765 (55.3%) female with mean age of 55.01&#xB1;17.85. Of total of 3207 participants, 146 (4.6%) had tinnitus consisting of 80 male (54.8%) and 66 (45.2%) female participants. It showed a rising trend with increasing age that was especially significant after the sixth decade of life (P=0.001). The analysis showed mean TQ global score of 35.96&#xB1;25.52 that was significantly different between male and female participants (P=0.051) and had no significant correlation with increasing age (Spearman's r=0.1, P=0.10). The tinnitus intensity was moderate to very severe in 95 (56.1%) of the participants. Its severity level was not significantly different between men and women (P=0.09). Tinnitus intensity had no significant association with increasing age (Spearman's r=0.1, P=0.31). Patients with higher TQ global score had higher tinnitus intensities (P=0.001). The annoyance level was significantly different between men and women (P=0.04) and its impact on the participants daily routine functions were significantly higher in men (P=0.003). Given the results of the study, demonstrating that prevalence of tinnitus in Iranian population (Tehran province) was lower than the other countries and had a direct correlation with increasing age only after the sixth decade. TQ global score had significant correlation with tinnitus intensity, annoyance and impact on the participants' daily routine functions. However, none of the above had correlation with increasing age. Tinnitus TQ global score and intensity were not different between men and women; however annoyance of tinnitus and its impact on participants' daily routine functions were significantly higher in men.</abstract>
    <web_url>https://acta.tums.ac.ir/index.php/acta/article/view/4329</web_url>
    <pdf_url>https://acta.tums.ac.ir/index.php/acta/article/download/4329/4552</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Acta Medica Iranica</JournalTitle>
      <Issn>0044-6025</Issn>
      <Volume>51</Volume>
      <Issue>12</Issue>
      <PubDate PubStatus="epublish">
        <Year>2013</Year>
        <Month>12</Month>
        <Day>15</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Helicobacter pylori Seropositivity in Patients with Type 2 Diabetes Mellitus in South-East of Iran</title>
    <FirstPage>892</FirstPage>
    <LastPage>896</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Abdollah</FirstName>
        <LastName>Jafarzadeh</LastName>
        <affiliation locale="en_US">Department of Microbiology and Immunology, Medical School, and Molecular Medicine Research Center, Rafsanjan University of Medical Sciences, Rafsanjan, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Mohammad Taghi</FirstName>
        <LastName>Rezayati</LastName>
        <affiliation locale="en_US">Department of Microbiology and Immunology, Medical School, and Molecular Medicine Research Center, Rafsanjan University of Medical Sciences, Rafsanjan, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Maryam</FirstName>
        <LastName>Nemati</LastName>
        <affiliation locale="en_US">Department of Microbiology and Immunology, Kerman University of Medical Sciences, Kerman, Iran.</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2015</Year>
        <Month>10</Month>
        <Day>11</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">It has been also reported that that H. pylori infection may be responsible for some endocrine disorders, such as autoimmune thyroid diseases, diabetes mellitus and primary hyperparathyroidism. H. pylori which express cytotoxin-associated gene A (CagA) may be more virulent than those that do not. The aim was to evaluate the seroprevalence of anti-H. pylori IgG and anti-CagA&#xA0; antibodies in patients with type 2 diabetes mellitus (type 2 DM) and healthy individuals from Rafsanjan city (Iran). A total of 100 patients with type 2 diabetes and 100 age-matched healthy individuals were enrolled to study. A blood sample was collected from each participant. The type 2 DM established according to the fasting blood glucose level of 126 mg/dl. The sera were tested for the presence of anti-H. pylori IgG antibodies and antibody to CagA by use of enzyme linked immunosorbent assay. The seroprevalence of anti-H. pylori antibodies in diabetic&#xA0; patients (76%) was similar to that observed in healthy subjects (75%). The mean titer of anti-H. pylori IgG in healthy control group (131.63&#xB1;11.68 U/ml) was significantly higher than diabetic group (54.43&#xB1;4.50 U/ml; P&lt;0.0001). The prevalence of serum anti-CagA IgG antibodies was 78.9% in infected diabetic patients and 77.3% in healthy control group with mean titer of 75.02&#xB1;4.54 U/ml and 84.34&#xB1;5.85 U/ml, respectively. No significant differences were observed between diabetic and healthy control groups regarding the prevalence and the mean titer of anti-CagA IgG antibodies. In the diabetic group, the seropositive rate of anti-H. pylori IgG was higher in women as compared to men, but the difference was not statistically significant. These results show that H. pylori seropositivity rate was similar in type 2 DM patients and non-diabetics control group. No association was also found between CagA-positive strains of H. pylori and type 2 DM.</abstract>
    <web_url>https://acta.tums.ac.ir/index.php/acta/article/view/4328</web_url>
    <pdf_url>https://acta.tums.ac.ir/index.php/acta/article/download/4328/4553</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Acta Medica Iranica</JournalTitle>
      <Issn>0044-6025</Issn>
      <Volume>51</Volume>
      <Issue>12</Issue>
      <PubDate PubStatus="epublish">
        <Year>2013</Year>
        <Month>12</Month>
        <Day>15</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Medical Student's Benefit Rates from the Clinical Teaching Rounds and Its Associated Factors in Tehran University of Medical Sciences in the Year 2010</title>
    <FirstPage>897</FirstPage>
    <LastPage>902</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Seyed Mansour</FirstName>
        <LastName>Razavi</LastName>
        <affiliation locale="en_US">Department of Community Medicine, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Jaber</FirstName>
        <LastName>Mahmoudi</LastName>
        <affiliation locale="en_US">Educational Development Center, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Zinat Nadia</FirstName>
        <LastName>Hatmi</LastName>
        <affiliation locale="en_US">Department of Community Medicine, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Mandana</FirstName>
        <LastName>Shirazi</LastName>
        <affiliation locale="en_US">Educational Development Center, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2015</Year>
        <Month>10</Month>
        <Day>11</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Among the various methods of clinical teaching, rounds and grand rounds are considered as the gold standards. Clinical round includes some standard components and it plays an effective role in student's learning process. The aim of this study was to evaluate the content of teaching rounds in 40 clinical wards in 4 medical teaching hospitals affiliated to Tehran University of Medical Sciences in Tehran, Iran, and also to assess the learners benefit rate from these programs and determine the factors affecting those. This is a cross sectional, descriptive and analytical study conducted on 318 medical learners in different grades, about the content of clinical rounds. The data collection tool was a questionnaire made by researchers. The validity of the questionnaire according to experts opinions and the reliability with a pilot study conducted on 30 cases were confirmed (&#x3B1;=0.826). Data entered into the SPSS software and for analysis Chi-square, Student's t-test, ANOVA and linear regression analysis tests were used. In this study 20 subjects related to clinical rounds content were assessed. The highest score was related to the subject of diagnosis and the lowest one was related to legal issues. Overall, the mean score of the learner's benefit rate to this method was 3.52 out of five. The level of learner's benefit rate was above the average and the benefit rates according to educational grade, number of the students and faculties were significantly different (P&lt;0.05). Average of the benefit rate among residents were significantly higher than the other medical trainees (P&lt;0.05). In conclusion, in understudied clinical rounds, there has been more emphasized on history taking, clinical examinations and diagnosis subjects, and Issues like: accountability, health economy, patient's nutrition, non-drug treatments and medical legal issues are less considered in the studied rounds.</abstract>
    <web_url>https://acta.tums.ac.ir/index.php/acta/article/view/4327</web_url>
    <pdf_url>https://acta.tums.ac.ir/index.php/acta/article/download/4327/4554</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Acta Medica Iranica</JournalTitle>
      <Issn>0044-6025</Issn>
      <Volume>51</Volume>
      <Issue>12</Issue>
      <PubDate PubStatus="epublish">
        <Year>2013</Year>
        <Month>12</Month>
        <Day>15</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Spontaneous Nystagmus in Benign Paroxysmal Positional Vertigo: Is It A New Sign?</title>
    <FirstPage>903</FirstPage>
    <LastPage>906</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Fahimeh</FirstName>
        <LastName>Hajiabolhassan</LastName>
        <affiliation locale="en_US">Department of Audiology, Faculty of Rehabilitation, Tehran University of Medical Science, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Elham</FirstName>
        <LastName>Tavanai</LastName>
        <affiliation locale="en_US">Department of audiology, Faculty of Rehabilitation, Tehran University of Medical Science, Tehran, Iran.</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2015</Year>
        <Month>10</Month>
        <Day>11</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Benign Paroxysmal Positional Vertigo (BPPV) is a condition that indicates a benign inner ear disorder. It is generally believed that BPPV is due to the dislodged otoconial particles from otolith organs and unusual collection of them within any of semicircular canals or even in all three semicircular canals. Although the typical features of nystagmus in BPPV have been well-studied, very few studies (just four articles) have highlighted the presence of spontaneous nystagmus in BPPV recently. During the past 10 years, 2850 patients have been examined at the audiology unit of our department, and 254 patients have received diagnoses of BPPV but recently 2 patients presented with BPPV and spontaneous nystagmus, a new symptom that has been never observed in our clinical records. We herein describe this rare symptom in 2 case of BPPV. A 50-year-old woman with BPPV who showed an 18 degree spontaneous nystagmus treated with Epley maneuver and a 53-year-old man with 3 degree spontaneous nystagmus.</abstract>
    <web_url>https://acta.tums.ac.ir/index.php/acta/article/view/4326</web_url>
    <pdf_url>https://acta.tums.ac.ir/index.php/acta/article/download/4326/4555</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Acta Medica Iranica</JournalTitle>
      <Issn>0044-6025</Issn>
      <Volume>51</Volume>
      <Issue>12</Issue>
      <PubDate PubStatus="epublish">
        <Year>2013</Year>
        <Month>12</Month>
        <Day>15</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Fraccaro Syndrome: Report of Two Iranian Cases: An Infant and an Adult in A Family</title>
    <FirstPage>907</FirstPage>
    <LastPage>909</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Fatemeh</FirstName>
        <LastName>Hadipour</LastName>
        <affiliation locale="en_US">Department of Medical Genetics, Sarem Cell Research Center &amp; Hospital, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Yousef</FirstName>
        <LastName>Shafeghati</LastName>
        <affiliation locale="en_US">Department of Medical Genetics, Sarem Cell Research Center &amp; Hospital, Tehran, Iran. AND Genetics Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Eiman</FirstName>
        <LastName>Bagherizadeh</LastName>
        <affiliation locale="en_US">Department of Medical Genetics, Sarem Cell Research Center &amp; Hospital, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Farkhondeh</FirstName>
        <LastName>Behjati</LastName>
        <affiliation locale="en_US">Department of Medical Genetics, Sarem Cell Research Center &amp; Hospital, Tehran, Iran. AND Genetics Research Center, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Zahra</FirstName>
        <LastName>Hadipour</LastName>
        <affiliation locale="en_US">Department of Medical Genetics, Sarem Cell Research Center &amp; Hospital, Tehran, Iran.</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2015</Year>
        <Month>10</Month>
        <Day>11</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">49,XXXXY is rare chromosomal pattern and these patients have mental retardation, small penis, cryptorchidism and skeletal anomalies. We reported a 10 month-old boy who has hypotonia, microcephaly, hypertelorism, depressed nasal bridge, epicanthic folds and bilateral multiple ear tags, high arched palate, down set ears, micrognathia and congenital heart disease such as patent ductus arteriosus (PDA), Atrial septal defect (ASD), mild pulmonary stenosis. Among the skeletal anomalies, he has kyphoscoliosis, clinodactyly of the fourth and fifth fingers of both hands, and bilateral club foot and unilateral dysplasia of the hip. Karyotype was found as 49,XXXXY[44]/48,XXXY[6] and this cytogenetic analysis was help to establish clinical diagnosis Fraccaro syndrome.</abstract>
    <web_url>https://acta.tums.ac.ir/index.php/acta/article/view/4325</web_url>
    <pdf_url>https://acta.tums.ac.ir/index.php/acta/article/download/4325/4556</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Acta Medica Iranica</JournalTitle>
      <Issn>0044-6025</Issn>
      <Volume>51</Volume>
      <Issue>12</Issue>
      <PubDate PubStatus="epublish">
        <Year>2013</Year>
        <Month>12</Month>
        <Day>15</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Acute Cholangitis Due to Anomaly of Right Hepatic Artery</title>
    <FirstPage>910</FirstPage>
    <LastPage>912</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Ramin</FirstName>
        <LastName>Niknam</LastName>
        <affiliation locale="en_US">Gastroenterohepatology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Laleh</FirstName>
        <LastName>Mahmoudi</LastName>
        <affiliation locale="en_US">Department of Clinical Pharmacy, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Reza</FirstName>
        <LastName>Ansari</LastName>
        <affiliation locale="en_US">Digestive Disease Research Institute, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2015</Year>
        <Month>10</Month>
        <Day>11</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Acute cholangitis (AC) is commonly observed in general practice with different causes. We report a case of recurrent AC caused by anomaly of the right hepatic artery, as a rare underlying condition.</abstract>
    <web_url>https://acta.tums.ac.ir/index.php/acta/article/view/4324</web_url>
    <pdf_url>https://acta.tums.ac.ir/index.php/acta/article/download/4324/4557</pdf_url>
  </Article>
</Articles>
